169 related articles for article (PubMed ID: 34435736)
1. Normocalcaemic primary hyperparathyroidism: is nephrolithiasis more common than osteoporosis?
Wu KCJ; Anpalahan M
Intern Med J; 2023 Jan; 53(1):112-118. PubMed ID: 34435736
[TBL] [Abstract][Full Text] [Related]
2. Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism.
Choi HR; Choi SH; Hong N; Rhee Y; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
J Korean Med Sci; 2022 Apr; 37(13):e99. PubMed ID: 35380024
[TBL] [Abstract][Full Text] [Related]
3. High Rate of Occult Urolithiasis in Normocalcemic Primary Hyperparathyroidism.
Lemos ALP; Andrade SRL; Pontes LLH; Teixeira PMC; Bandeira E; Bandeira LC; Bandeira F
Kidney Blood Press Res; 2019; 44(5):1189-1195. PubMed ID: 31542783
[TBL] [Abstract][Full Text] [Related]
4. Normocalcemic Primary Hyperparathyroidism: A Comparison with the Hypercalcemic Form in a Tertiary Referral Population.
Pierreux J; Bravenboer B
Horm Metab Res; 2018 Nov; 50(11):797-802. PubMed ID: 30396209
[TBL] [Abstract][Full Text] [Related]
5. The impact of obesity on the presentation of primary hyperparathyroidism.
Tran H; Grange JS; Adams-Huet B; Nwariaku FE; Rabaglia JL; Woodruff SL; Holt SA; Maalouf NM
J Clin Endocrinol Metab; 2014 Jul; 99(7):2359-64. PubMed ID: 24684459
[TBL] [Abstract][Full Text] [Related]
6. Normocalcaemic primary hyperparathyroidism: what is the role of parathyroid surgery?
Aojula N; Khan S; Gittoes N; Hassan-Smith Z
Ther Adv Endocrinol Metab; 2021; 12():2042018821995370. PubMed ID: 33717430
[TBL] [Abstract][Full Text] [Related]
7. New parathyroid function index for the differentiation of primary and secondary hyperparathyroidism: a case-control study.
Guo Y; Wang Q; Lu C; Fan P; Li J; Luo X; Chen D
BMC Endocr Disord; 2020 Jan; 20(1):5. PubMed ID: 31914999
[TBL] [Abstract][Full Text] [Related]
8. Normocalcemic Primary Hyperparathyroidism in Adults Without a History of Nephrolithiasis or Fractures: A Prospective Study.
Rosário PW; Calsolari MR
Horm Metab Res; 2019 Apr; 51(4):243-247. PubMed ID: 30840998
[TBL] [Abstract][Full Text] [Related]
9. Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History.
Schini M; Jacques RM; Oakes E; Peel NFA; Walsh JS; Eastell R
J Clin Endocrinol Metab; 2020 Apr; 105(4):e1171-86. PubMed ID: 32072184
[TBL] [Abstract][Full Text] [Related]
10. Is Normocalcemic Primary Hyperparathyroidism Harmful or Harmless?
Chen G; Xue Y; Zhang Q; Xue T; Yao J; Huang H; Liang J; Li L; Lin W; Lin L; Shi L; Cai L; Wen J
J Clin Endocrinol Metab; 2015 Jun; 100(6):2420-4. PubMed ID: 25668199
[TBL] [Abstract][Full Text] [Related]
11. Normocalcemic primary hyperparathyroidism.
Cusano NE; Cetani F
Arch Endocrinol Metab; 2022 Nov; 66(5):666-677. PubMed ID: 36382756
[TBL] [Abstract][Full Text] [Related]
12. Biochemical characteristics and clinical manifestation of normocalcemic primary hyperparathyroidism.
Yankova I; Lilova L; Petrova D; Dimitrova I; Stoynova M; Shinkov A; Kovatcheva R
Endocrine; 2024 Mar; ():. PubMed ID: 38489132
[TBL] [Abstract][Full Text] [Related]
13. Normocalcaemic primary hyperparathyroidism: a diagnostic and therapeutic algorithm.
Gómez-Ramírez J; Mihai R
Langenbecks Arch Surg; 2017 Nov; 402(7):1103-1108. PubMed ID: 28823005
[TBL] [Abstract][Full Text] [Related]
14. Effects of alendronate and vitamin D in patients with normocalcemic primary hyperparathyroidism.
Cesareo R; Di Stasio E; Vescini F; Campagna G; Cianni R; Pasqualini V; Romitelli F; Grimaldi F; Manfrini S; Palermo A
Osteoporos Int; 2015 Apr; 26(4):1295-302. PubMed ID: 25524023
[TBL] [Abstract][Full Text] [Related]
15. Hypomagnesuria is Associated With Nephrolithiasis in Patients With Asymptomatic Primary Hyperparathyroidism.
Saponaro F; Marcocci C; Apicella M; Mazoni L; Borsari S; Pardi E; Di Giulio M; Carlucci F; Scalese M; Bilezikian JP; Cetani F
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32369583
[TBL] [Abstract][Full Text] [Related]
16. Normocalcemic primary hyperparathyroidism: a survey in a small village of Southern Italy.
Vignali E; Cetani F; Chiavistelli S; Meola A; Saponaro F; Centoni R; Cianferotti L; Marcocci C
Endocr Connect; 2015 Sep; 4(3):172-8. PubMed ID: 26155986
[TBL] [Abstract][Full Text] [Related]
17. The Ca∗Cl/P Ratio: A Novel and More Appropriate Screening Tool for Normocalcaemic or Overt Primary Hyperparathyroidism.
Yu Y; Qiu J; Chuan F; Feng Z; Long J; Zhou B
Endocr Pract; 2024 Mar; 30(3):231-238. PubMed ID: 38086525
[TBL] [Abstract][Full Text] [Related]
18. Normocalcemic primary hyperparathyroidism is an early stage of primary hyperparathyroidism according to fibroblast growth factor 23 level.
Chertok Shacham E; Maman N; Lazareva T; Masalha R; Mahagna L; Sela G; Ishay A
Front Endocrinol (Lausanne); 2023; 14():1152464. PubMed ID: 37065752
[TBL] [Abstract][Full Text] [Related]
19. Parathyroidectomy for Normocalcemic Primary Hyperparathyroidism is Associated with Improved Bone Mineral Density Regardless of Postoperative Parathyroid Hormone Levels.
Lui MS; Clemente-Gutierrez U; Vodopivec DM; Chang SL; Shirali AS; Huang BL; Chiang YJ; Fisher SB; Grubbs EG; Guise TA; Graham PH; Perrier ND
World J Surg; 2023 Feb; 47(2):363-370. PubMed ID: 36195677
[TBL] [Abstract][Full Text] [Related]
20. Occult Renal Calcifications in Patients with Normocalcemic Primary Hyperparathyroidism and Their Association with the Parathyroid Hormone-Vitamin D Axis.
Victor F; Pereira Lemos AL; de Holanda Ribas AM; Bandeira L; Pimentel JH; de Andrade Damázio LO; Bandeira F
Int J Endocrinol; 2022; 2022():4558236. PubMed ID: 35437440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]